MAP-kinases Erk1/2 activation Dotaz Zobrazit nápovědu
Cyanobacterial toxin cylindrospermopsin (CYN) is an emerging freshwater contaminant, whose expanding environmental occurrence might result into increased human health risks. CYN is potent hepatotoxin, with cytotoxicity and genotoxicity documented in primary hepatocytes or hepatoma cell lines. However, there is only limited information about CYN effects on adult human liver stem cells (LSCs), which play an important role in liver tissue development, regeneration and repair. In our study with human liver cell line HL1-hT1 which expresses characteristics of LSCs, CYN was found to be cytotoxic and increasing cell death after 24-48 h exposure to concentrations >1 μM. Subcytotoxic 1 μM concentration did not induce cell death or membrane damage, but inhibited cellular processes related to energy production, leading to a growth stagnation after >72 h. Interestingly, these effects were not associated with increased DNA damage, reactive oxygen species production, or endoplasmic reticulum stress. However, CYN induced a sustained (24-48 h) activation of mitogen-activated protein kinases ERK1/2 and p38, and increased expression of stress-related transcription factor ATF3. Thus, LSCs were not primarily affected by CYN-induced genotoxicity and oxidative stress, but via activation of signaling and transcriptional pathways critical for regulation of cell proliferation, stress responses, cell survival and inflammation. Alterations of LSCs during CYN-induced liver injury, including the role of nongenotoxic mechanisms, should be therefore considered in mechanistic assessments of chronic CYN hepatotoxicity and hepatocarcinogenicity.
- Klíčová slova
- Adult human liver stem cells HL1-hT1, Cylindrospermopsin, DNA damage, Mitogen-activated protein kinases, Nongenotoxic mechanisms, Oxidative stress,
- MeSH
- alkaloidy MeSH
- bakteriální toxiny toxicita MeSH
- buněčné linie MeSH
- hepatocyty účinky léků MeSH
- játra metabolismus MeSH
- kmenové buňky MeSH
- lidé MeSH
- MAP kinasový signální systém MeSH
- mikrocystiny MeSH
- mitogenem aktivovaná proteinkinasa 1 metabolismus MeSH
- mitogenem aktivovaná proteinkinasa 3 metabolismus MeSH
- mitogenem aktivované proteinkinasy p38 metabolismus MeSH
- mořské toxiny MeSH
- oxidační stres účinky léků MeSH
- poškození DNA MeSH
- proliferace buněk MeSH
- reaktivní formy kyslíku metabolismus MeSH
- testy toxicity MeSH
- toxiny kmene Cyanobacteria MeSH
- uracil analogy a deriváty toxicita MeSH
- viabilita buněk účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- alkaloidy MeSH
- bakteriální toxiny MeSH
- cylindrospermopsin MeSH Prohlížeč
- MAPK1 protein, human MeSH Prohlížeč
- mikrocystiny MeSH
- mitogenem aktivovaná proteinkinasa 1 MeSH
- mitogenem aktivovaná proteinkinasa 3 MeSH
- mitogenem aktivované proteinkinasy p38 MeSH
- mořské toxiny MeSH
- reaktivní formy kyslíku MeSH
- toxiny kmene Cyanobacteria MeSH
- uracil MeSH
BACKGROUND: 9-[2-(phosphonomethoxy)ethyl] guanine (PMEG) is a nucleotide analogue with anticancer activity. Here we investigate the role of ERK, p38, JNK and AKT kinases in PMEG-induced apoptosis. MATERIALS AND METHODS: CCRF-CEM and HL-60 leukemia cells were used to assess MAPK mRNA and protein expression in PMEG-treated cells. MAPK activation was measured using phospho-specific antibodies. Apoptosis was evaluated by caspase-3 and PARP cleavage. RESULTS: Up-regulation of p38β, γ and δ mRNA were observed following PMEG treatment of CCRF-CEM cells, however, the total protein expression remained unchanged. Neither PMEG nor its analogue 9-[2-(phosphonomethoxy) ethyl]-2,6-diaminopurine (PMEDAP) induced p38 kinase phosphorylation in CCRF-CEM cells, whereas increased p38 phosphorylation was observed in HL-60 cells. The ERK pathway was also activated by these compounds. Pretreatment of the cells with the p38 inhibitor SB203580 diminished drug-induced apoptosis whereas inhibition of ERK, JNK or AKT pathways did not. [corrected]. CONCLUSION: PMEG- and PMEDAP-induced. [corrected].
- MeSH
- adenin analogy a deriváty farmakologie MeSH
- aktivace enzymů účinky léků MeSH
- antitumorózní látky farmakologie MeSH
- extracelulárním signálem regulované MAP kinasy antagonisté a inhibitory metabolismus MeSH
- guanin analogy a deriváty farmakologie MeSH
- HL-60 buňky MeSH
- kaspasa 3 metabolismus MeSH
- lidé MeSH
- MAP kinasa-kinasa 4 antagonisté a inhibitory metabolismus MeSH
- MAP kinasový signální systém účinky léků MeSH
- messenger RNA biosyntéza genetika MeSH
- mitogenem aktivované proteinkinasy p38 antagonisté a inhibitory biosyntéza genetika metabolismus MeSH
- mitogenem aktivované proteinkinasy antagonisté a inhibitory biosyntéza genetika metabolismus MeSH
- nádorové buněčné linie MeSH
- organofosforové sloučeniny farmakologie MeSH
- protoonkogenní proteiny c-akt antagonisté a inhibitory metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- 9-((2-phosphonylmethoxy)ethyl)guanine MeSH Prohlížeč
- 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine MeSH Prohlížeč
- adenin MeSH
- antitumorózní látky MeSH
- extracelulárním signálem regulované MAP kinasy MeSH
- guanin MeSH
- kaspasa 3 MeSH
- MAP kinasa-kinasa 4 MeSH
- messenger RNA MeSH
- mitogenem aktivované proteinkinasy p38 MeSH
- mitogenem aktivované proteinkinasy MeSH
- organofosforové sloučeniny MeSH
- protoonkogenní proteiny c-akt MeSH
Fusarium-derived mycotoxin deoxynivalenol (DON) usually induces diarrhea, vomiting and gastrointestinal inflammation. We studied the cytotoxic effect of DON on porcine small intestinal epithelium using the intestinal porcine epithelial cell line IPEC-J2. We screened out differentially expressed genes (DEGs) using RNA-seq and identified 320 upregulated genes and 160 downregulated genes. The enrichment pathways of these DEGs focused on immune-related pathways. DON induced proinflammatory gene expression, including cytokines, chemokines and other inflammation-related genes. DON increased IL1A, IL6 and TNF-α release and DON activated the phosphorylation of extracellular signal-regulated kinase-1 and-2 (ERK1/2), JUN N-terminal kinase (JNK) and p38 MAPK. A p38 inhibitor attenuated DON-induced IL6, TNF-α, CXCL2, CXCL8, IL12A, IL1A, CCL20, CCL4 and IL15 production, while an ERK1/2 inhibitor had only a small inhibitory effect on IL15 and IL6. An inhibitor of p38 MAPK decreased the release of IL1A, IL6 and TNF-α and an inhibitor of ERK1/2 partly attenuated protein levels of IL6. These data demonstrate that DON induces proinflammatory factor production in IPEC-J2 cells by activating p38 and ERK1/2.
- Klíčová slova
- IPEC-J2 cells, MAPKs, RNA-seq, deoxynivalenol, inflammation,
- MeSH
- buněčné linie MeSH
- epitelové buňky účinky léků imunologie metabolismus MeSH
- interleukin-1 genetika MeSH
- interleukin-6 genetika MeSH
- MAP kinasový signální systém účinky léků genetika imunologie MeSH
- mitogenem aktivované proteinkinasy p38 metabolismus MeSH
- prasata MeSH
- střevní sliznice účinky léků imunologie metabolismus MeSH
- TNF-alfa genetika MeSH
- transkriptom účinky léků MeSH
- trichotheceny toxicita MeSH
- viabilita buněk účinky léků MeSH
- zánět MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- deoxynivalenol MeSH Prohlížeč
- interleukin-1 MeSH
- interleukin-6 MeSH
- mitogenem aktivované proteinkinasy p38 MeSH
- TNF-alfa MeSH
- trichotheceny MeSH
Although the involvement of the extracellular signal-regulated kinases 1 and 2 (ERK1/2) pathway in the regulation of cytostatic factor (CSF) activity; as well as in microtubules organization during meiotic maturation of oocytes; has already been described in detail; rather less attention has been paid to the role of ERK1/2 in the regulation of mRNA translation. However; important data on the role of ERK1/2 in translation during oocyte meiosis have been documented. This review focuses on recent findings regarding the regulation of translation and the role of ERK1/2 in this process in the meiotic cycle of mammalian oocytes. The specific role of ERK1/2 in the regulation of mammalian target of rapamycin (mTOR); eukaryotic translation initiation factor 4E (eIF4E) and cytoplasmic polyadenylation element binding protein 1 (CPEB1) activity is addressed along with additional focus on the other key players involved in protein translation.
- Klíčová slova
- CPEB1, ERK1/2, MAP kinase, eIF4E, mTOR, oocyte, translation,
- MeSH
- cytoplazma genetika metabolismus MeSH
- eukaryotický iniciační faktor 4E metabolismus MeSH
- faktory štěpení a polyadenylace mRNA metabolismus MeSH
- fosfatidylinositol-3-kinasy metabolismus MeSH
- lidé MeSH
- meióza * MeSH
- messenger RNA genetika metabolismus MeSH
- mitogenem aktivovaná proteinkinasa 1 metabolismus MeSH
- mitogenem aktivovaná proteinkinasa 3 metabolismus MeSH
- mitogenem aktivované proteinkinasy metabolismus MeSH
- oocyty metabolismus MeSH
- polyadenylace MeSH
- proteosyntéza * MeSH
- signální transdukce MeSH
- TOR serin-threoninkinasy metabolismus MeSH
- vazba proteinů MeSH
- vývojová regulace genové exprese MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- eukaryotický iniciační faktor 4E MeSH
- faktory štěpení a polyadenylace mRNA MeSH
- messenger RNA MeSH
- mitogenem aktivovaná proteinkinasa 1 MeSH
- mitogenem aktivovaná proteinkinasa 3 MeSH
- mitogenem aktivované proteinkinasy MeSH
- TOR serin-threoninkinasy MeSH
Deregulation of various signaling pathways, linked either to induction of cell proliferation or to modulation of cellular differentiation and apoptosis, has been proposed to contribute to carcinogenicity of polycyclic aromatic hydrocarbons (PAHs). In the present study, we investigated effects of the PAHs previously shown to induce cell proliferation and/or apoptosis in contact-inhibited rat liver epithelial WB-F344 cells, with an aim to define the role of mitogen-activated protein kinases in both events. We found that only strong genotoxin dibenzo[a,l]pyrene (DBalP) activated extracellular signal-regulated kinases 1 and 2 (ERK1/2) and p38 kinase, but not c-Jun N-terminal kinases (JNKs), at concentrations inducing both apoptosis and phosphorylation of p53 tumor suppressor at serine 15 residue. In contrast, the PAHs stimulating cell proliferation in WB-F344 cell line had no effect on activation of ERK1/2, p38 or JNKs. Synthetic inhibitors of ERK1/2 activation (U0126) or p38 kinase activity (SB203580) prevented both apoptosis and induction of p53 phosphorylation by DBalP. Pifithrin-alpha, inhibitor of p53 transcriptional activity, prevented induction of apoptosis and activation of ERK1/2 and p38. Taken together, our data suggest that both ERK1/2 and p38 are activated in response to DBalP and that they might be involved in regulation of cellular response to DNA damage induced by DBalP, while neither kinase is involved in the release from contact inhibition induced by PAHs.
- MeSH
- aktivace enzymů účinky léků MeSH
- apoptóza účinky léků MeSH
- buněčné linie MeSH
- buněčný cyklus účinky léků MeSH
- epitelové buňky * cytologie účinky léků enzymologie MeSH
- extracelulárním signálem regulované MAP kinasy metabolismus MeSH
- fosforylace MeSH
- inhibitory enzymů farmakologie MeSH
- játra * cytologie účinky léků enzymologie MeSH
- JNK mitogenem aktivované proteinkinasy metabolismus MeSH
- krysa rodu Rattus MeSH
- mitogenem aktivované proteinkinasy p38 metabolismus MeSH
- polycyklické aromatické uhlovodíky toxicita MeSH
- proliferace buněk účinky léků MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- extracelulárním signálem regulované MAP kinasy MeSH
- inhibitory enzymů MeSH
- JNK mitogenem aktivované proteinkinasy MeSH
- mitogenem aktivované proteinkinasy p38 MeSH
- polycyklické aromatické uhlovodíky MeSH
The interactions between TRPV1 and µ-opioid receptors (MOR) have recently attracted much attention because these two receptors play important roles in pain pathways and can apparently modulate each other's functioning. However, the knowledge about signaling interactions and crosstalk between these two receptors is still limited. In this study, we investigated the mutual interactions between MOR and TRPV1 shortly after their activation in HEK293 cells expressing these two receptors. After activation of one receptor we observed significant changes in the other receptor's lateral mobility and vice versa. However, the changes in receptor movement within the plasma membrane were not connected with activation of the other receptor. We also observed that plasma membrane β-arrestin 2 levels were altered after treatment with agonists of both these receptors. Knockdown of β-arrestin 2 blocked all changes in the lateral mobility of both receptors. Furthermore, we found that β-arrestin 2 can play an important role in modulating the effectiveness of ERK1/2 phosphorylation after activation of MOR in the presence of TRPV1. These data suggest that β-arrestin 2 and ERK1/2 are important mediators between these two receptors and their signaling pathways. Collectively, MOR and TRPV1 can mutually affect each other's behavior and β-arrestin 2 apparently plays a key role in the bidirectional crosstalk between these two receptors in the plasma membrane.
- Klíčová slova
- ERK1/2, TRPV1, biased signaling, receptor lateral mobility, β-arrestin 2, μ-opioid receptor,
- MeSH
- arrestiny metabolismus MeSH
- beta arrestin 2 metabolismus fyziologie MeSH
- beta arrestiny metabolismus MeSH
- buněčná membrána metabolismus fyziologie MeSH
- fosforylace MeSH
- HEK293 buňky MeSH
- kationtové kanály TRPV metabolismus fyziologie MeSH
- lidé MeSH
- MAP kinasový signální systém fyziologie MeSH
- morfin metabolismus MeSH
- opioidní analgetika metabolismus MeSH
- receptory opiátové mu metabolismus fyziologie MeSH
- receptory opiátové metabolismus MeSH
- signální transdukce MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- arrestiny MeSH
- beta arrestin 2 MeSH
- beta arrestiny MeSH
- kationtové kanály TRPV MeSH
- morfin MeSH
- opioidní analgetika MeSH
- receptory opiátové mu MeSH
- receptory opiátové MeSH
- TRPV1 protein, human MeSH Prohlížeč
Humans are exposed to phthalates released from plastics, cosmetics, or food on a daily basis. Phthalates have low acute liver toxicity, but their chronic exposures could induce molecular and cellular effects linked to adverse health outcomes, such as liver tumor promotion or chronic liver diseases. The alternation of gap junctional intercellular communication (GJIC) and MAPK-Erk1/2 pathways in liver progenitor or oval cells can disrupt liver tissue homeostatic mechanisms and affect the development and severity of these adverse outcomes. Our study with 20 different phthalates revealed their structurally dependent effects on liver GJIC and MAPK-Erk1/2 signaling in rat liver WB-F344 cell line with characteristics of liver oval cells. The phthalates with a medium-length side chain (3-6 C) were the most potent dysregulators of GJIC and activators of MAPK-Erk1/2. The effects occurred rapidly, suggesting the activation of non-genomic (non-transcriptional) mechanisms directly by the parental compounds. Short-chain phthalates (1-2 C) did not dysregulate GJIC even after longer exposures and did not activate MAPK-Erk1/2. Longer chain (≥7 C) phthalates, such as DEHP or DINP, moderately activated MAPK-Erk1/2, but inhibited GJIC only after prolonged exposures (>12 h), suggesting that GJIC dysregulation occurs via genomic mechanisms, or (bio)transformation. Overall, medium-chain phthalates rapidly affected the key tissue homeostatic mechanisms in the liver oval cell population via non-genomic pathways, which might contribute to the development of chronic liver toxicity and diseases.
- Klíčová slova
- MAP-kinases Erk1/2 activation, gap junctional intercellular communication, gap junctions, hepatotoxicity, non-genomic mechanism, oval cells, phthalates, progenitor cells,
- MeSH
- buněčné linie MeSH
- játra cytologie účinky léků metabolismus MeSH
- krysa rodu Rattus MeSH
- kyseliny ftalové aplikace a dávkování chemie toxicita MeSH
- MAP kinasový signální systém účinky léků MeSH
- mezerový spoj účinky léků MeSH
- mezibuněčná komunikace účinky léků MeSH
- viabilita buněk účinky léků MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- vztahy mezi strukturou a aktivitou MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- kyseliny ftalové MeSH
The intrinsic period of circadian clock in the suprachiasmatic nucleus is entrained to a 24-h cycle by external cues, mainly light. Previous studies have shown that light applied at night induces robust phosphorylation of extracellular-signal-regulated kinase that is necessary to process the light pulse into the phase shift of the clock phase. In this study, we show the persistent downregulation of phosphorylated extracellular-signal-regulated kinase and transient downregulation of phosphorylated glycogen synthase kinase-3beta in the ventrolateral part of the suprachiasmatic nucleus to photic stimuli starting at 2 h after the beginning of the light pulse. As both kinases are involved in regulation of circadian clockwork, we hypothesize that these changes may contribute to the phase-shifting effect of light at night.
- MeSH
- cirkadiánní hodiny * MeSH
- GSK3B MeSH
- kinasa 3 glykogensynthasy metabolismus MeSH
- krysa rodu Rattus MeSH
- MAP kinasový signální systém MeSH
- mitogenem aktivovaná proteinkinasa 1 metabolismus MeSH
- mitogenem aktivovaná proteinkinasa 3 metabolismus MeSH
- nucleus suprachiasmaticus metabolismus fyziologie MeSH
- potkani Wistar MeSH
- reakční čas * MeSH
- světelná stimulace MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- Gsk3b protein, rat MeSH Prohlížeč
- GSK3B MeSH
- kinasa 3 glykogensynthasy MeSH
- mitogenem aktivovaná proteinkinasa 1 MeSH
- mitogenem aktivovaná proteinkinasa 3 MeSH
The relationship between signal pathways MEK1/2-ERK1/2 and ATM-p53 in the response to DNA damage is not well understood. The aim of our study was to investigate the effect of mitoxantrone and two protein kinase inhibitors - caffeine (inhibitor of ATM kinase) and U0126 (inhibitor of MEK1/2 kinase) - on MOLT-4 and Jurkat leukaemic cell lines. In this work we show that the inhibition of MEK1/2 is associated with an increased mortality of cells after mitoxantrone treatment. Inhibition of ATM by caffeine delayed mitoxantrone-induced cell death in MOLT-4 cells. Mitoxantrone itself induced cell-cycle arrest and accumulation of the cells in late S and G2/M phase. Inhibition of ATM, but not of MEK1/2, abrogated mitoxantrone-induced cell-cycle arrest. Inhibition of MEK1/2 did not change mitoxantroneinduced up-regulation of p53 and p21, but inhibition of ATM markedly decreased up-regulation of p53 and p21, and p53 phosphorylation on serine 15 and serine 392. It can be concluded that: 1) mitoxantrone- induced phosphorylation of p53 on serine 15 and serine 392 is ATM dependent and MEK1/2-ERK1/2 independent. 2) ATM inhibition by caffeine prevents G2 cell arrest and in p53-positive cells MOLT-4 delays the onset of mitoxantrone-induced cell death. 3) Inhibition of MEK1/2-ERK1/2 cascade potentiates the cytostatic effect of mitoxantrone regardless of the p53 status.
- MeSH
- antitumorózní látky farmakologie MeSH
- apoptóza * MeSH
- ATM protein MeSH
- buněčný cyklus MeSH
- butadieny farmakologie MeSH
- DNA vazebné proteiny antagonisté a inhibitory genetika MeSH
- G2 fáze účinky léků MeSH
- Jurkat buňky MeSH
- lidé MeSH
- mitogenem aktivovaná proteinkinasa 1 antagonisté a inhibitory MeSH
- mitogenem aktivovaná proteinkinasa 3 antagonisté a inhibitory genetika MeSH
- mitoxantron farmakologie MeSH
- nádorové buněčné linie MeSH
- nádorové supresorové proteiny antagonisté a inhibitory genetika MeSH
- nitrily farmakologie MeSH
- protein-serin-threoninkinasy antagonisté a inhibitory genetika MeSH
- proteiny buněčného cyklu antagonisté a inhibitory genetika MeSH
- signální transdukce MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- antitumorózní látky MeSH
- ATM protein, human MeSH Prohlížeč
- ATM protein MeSH
- butadieny MeSH
- DNA vazebné proteiny MeSH
- mitogenem aktivovaná proteinkinasa 1 MeSH
- mitogenem aktivovaná proteinkinasa 3 MeSH
- mitoxantron MeSH
- nádorové supresorové proteiny MeSH
- nitrily MeSH
- protein-serin-threoninkinasy MeSH
- proteiny buněčného cyklu MeSH
- U 0126 MeSH Prohlížeč
Eukaryotic initiation factor 4E (eIF4E) plays an important role in mRNA translation by binding the 5'-cap structure of the mRNA and facilitating the recruitment to the mRNA of other translation factors and the 40S ribosomal subunit. eIF4E undergoes regulated phosphorylation on Ser-209 and this phosphorylation is believed to be important for its binding to mRNA and to other initiation factors. The findings showing that the translation initiation factor eIF4E becomes gradually phosphorylated during in vitro maturation (IVM) of pig oocytes with a maximum in metaphase II (M II) stage oocytes have been documented by us recently (Ellederova et al., 2006). The aim of this work was to study in details the metabolic pathways involved in this process. Using inhibitors of cyclin-dependent kinases, Butyrolactone I (BL I) and protein phosphatases, okadaic acid (OA) we show that ERK1/2 MAP kinase pathway is involved in this phosphorylation. We also demonstrate that activation and phosphorylation of ERK1/2 MAP kinase and eIF4E is associated with the activating phosphorylation of Mnk1 kinase, one of the two main kinases phosphorylating eIF4E in somatic cells.
- MeSH
- eukaryotický iniciační faktor 4E genetika metabolismus MeSH
- fosforylace MeSH
- inhibitory enzymů farmakologie MeSH
- isoelektrická fokusace MeSH
- mitogenem aktivovaná proteinkinasa 3 metabolismus MeSH
- oocyty účinky léků fyziologie MeSH
- prasata MeSH
- zvířata MeSH
- Check Tag
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- eukaryotický iniciační faktor 4E MeSH
- inhibitory enzymů MeSH
- mitogenem aktivovaná proteinkinasa 3 MeSH